Related Experiment Videos
Hemostatic changes following the modified Fontan operation (total cavopulmonary connection)
1Children's Hospital of the Friedrich-Alexander-Universität, Erlangen-Nuernberg, Germany. ralf.rauch@dland.de
Thrombosis and Haemostasis
|May 24, 2000
Summary
Patients after Fontan operation show altered coagulation, with lower protein C and S levels, and higher Factor VIII (FVIII) levels. These changes suggest increased thrombin and plasmin generation, potentially increasing thromboembolism risk.
Area of Science:
- Cardiovascular Surgery
- Hematology
- Pediatric Cardiology
Background:
- Thromboembolism is a significant risk following the Fontan operation.
- Alterations in the coagulation system are suspected contributors to post-Fontan thromboembolism.
- Understanding these coagulation changes is crucial for managing patient outcomes.
Purpose of the Study:
- To investigate pro- and anticoagulant factors in patients after Fontan operation.
- To compare markers of thrombin activation and fibrinolysis between Fontan patients and healthy controls.
- To assess in vitro clotting and clot-lysis in this patient cohort.
Main Methods:
- Studied 20 patients (aged 4-21 years) 4-63 months post-total cavopulmonary connection.
- Measured levels of protein C, protein S, and Factor VIII (FVIII).
- Assessed markers of thrombin-antithrombin III (TAT), plasmin-antiplasmin (PAP), and prothrombin fragments F1+2.
Main Results:
- Fontan patients exhibited significantly lower protein C and protein S levels compared to controls.
- Approximately 50% of patients had elevated FVIII levels, indicating increased thrombotic risk.
- Increased TAT and PAP levels, with a trend in prothrombin fragments, suggested enhanced thrombin and plasmin generation.
Conclusions:
- Fontan operation is associated with a prothrombotic state due to decreased anticoagulant factors and increased procoagulant factors.
- Elevated thrombin and plasmin generation markers indicate a hypercoagulable state post-Fontan.
- These coagulation alterations may underlie the increased risk of thromboembolism in Fontan survivors.